Checkpoint Trend

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE396H01019
  • NSEID:
  • BSEID: 531099
INR
109.56
2.14 (1.99%)
BSENSE

Dec 05

BSE+NSE Vol: 2.89 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Checkpoint Trends Ltd stock-summary
stock-summary
Checkpoint Trends Ltd
Micro Cap
Pharmaceuticals & Biotechnology
Checkpoint Trends Limited (Formerly known as Rubra Medicaments Ltd) was established in 1991. The Company name was changed from Rubra Medicaments Limited to Checkpoint Trends Limited in April, 2022. It is presently into the business of trading. The Company possesses great experience in management and providing different kinds of consultancies in India. The main object of the Company is to cater to all categories of clients providing all types of consulting services.
Company Coordinates stock-summary
Company Details
604 6th Floor Meghdoot, Mogul Lines Staff CHSL JVPD Sc Mumbai Maharashtra : 400049
stock-summary
Tel: 91-9167469649
stock-summary
rubraltd@gmail.com
Registrar Details
Bigshare Services Pvt Ltd , G 10 Left Wing Amruta Village , Opp: Yashoda Hospital, Raj Bhavan Road, Somajiguda, Hyderabad
stock-summary Capital Structure
Capital Structure stock-summary
Present Equity Capital
INR None Cr
Number of Shares
None Cr
Face Value
INR None
Date
Number
of Shares(Cr)
Equity
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 3 FIIs (10.86%)

Promoter with highest holding

None

Highest Public shareholder

Religare Finvest Ltd (5.89%)

Individual Investors Holdings

73.69%

stock-summary Board of Directorsstock-summary
stock-summary
Management
Designation
Remuneration
Abha Kapoor
Director (Finance) & CFO
0
Sneha Thakur
Independent Director
0
Sunil Khandelwal
Managing Director
0
Gopal Sahu
Independent Director
0
Ritu Chhatani
Company Sec. & Compli. Officer
0
Harish Surve
Independent Director
0
stock-recommendationRaw Materials
Raw Materials Dashboard stock-summary
Raw Materials
Amount(Rs Cr)
% of RM Cost
 
Icon
No Data Available
stock-recommendation Finished Goods
Finished Goods Dashboard stock-summary
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Traded Goods
2.30
100.00%
 
100
Traded Goods
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
109 Cr
(Quarterly Results - Sep 2025)
Net Profit:
1 Cr
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

INR 59 Cr (Micro Cap)

stock-summary
P/E

41.00

stock-summary
Industry P/E

34

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.07

stock-summary
Return on Equity

73.46%

stock-summary
Price to Book

29.82